|  30 day returns  |  lab tested  |  fast worldwide delivery

Doctor’s research shows that COVID-19 patients are improved with NMN cocktail therapy

Patients with COVID-19 who received nicotinamide mononucleotide (NMN) cocktail therapy showed clinical improvement. The molecule nicotinamide mononucleotide (NMN) is a promising anti-aging agent that can increase the level of essential molecules for cell energy production and cell health maintenance, called nicotinamide adenine dinucleotide (NAD+). In studies using mice, increasing levels of NAD+ and its precursor NMN have reversed age-related declines in kidney, liver, brain, blood vessel, and immune system function. The researchers also proposed that increasing the level of NAD+ can enhance the immune response to infections, including SARS-CoV-2 infection. Huizenga published a non-peer-reviewed study in which he used the NMN cocktail to treat elderly people with SARS-CoV-2 infection and found that with this treatment option, clinical parameters have been rapidly and significantly improved .

After taking the NMN cocktail, the inflammatory markers in the blood of the patient decreased and the white blood cell (lymphocyte) count increased. Huizenga administers 83 ml of NMN cocktail and 400 ml of water to patients with COVID-19 infection in the study twice a day before breakfast and dinner. The cocktail consists of non-prescription NMN at an unspecified concentration and three boosters. Huizenga believes that these boosters can optimize the activity of NAD+-dependent proteins, called Sirtuins, which play an important role in maintaining cell health. The booster contained in the NMN cocktail includes a compound isolated from sugar beet called betaine to combat NAD+ decomposition or inhibition, sodium chloride to enhance the absorption of NMN in the body, and zinc to increase nuclear factor red blood cell 2 related factor 2 Function. Nrf2), a protein that protects cells from damage or cellular stress caused by inflammation.

Study included nine, in average 65 years old, COVID-19 infected patients.